Sector revisions Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 28/07/2026 BST			Pre-market 14:06:43
490.39 ^USD	+2.38%		499.26	+1.81%

01:21pm	Abcellera Biologics Inc. Announces Collaboration with Vertex Pharmaceuticals Incorporated to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions	CI
07-21	Morgan Stanley Downgrades Vertex Pharmaceuticals to Equalweight From Overweight, Adjusts PT to $15 From $19	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	VERTEX PHARMACEUTICALS INCORPORATED							23
	ELI LILLY AND COMPANY							26
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	ROCHE HOLDING AG							18
	NOVARTIS AG							21
	ASTRAZENECA PLC							22
	NOVO NORDISK A/S							24
	AMGEN INC.							29
	GILEAD SCIENCES, INC.							27
	PFIZER INC.							26
	BRISTOL-MYERS SQUIBB COMPANY							24
	SANOFI							23
	GSK PLC							20
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							16
	BAYER AG							18
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							15
	HALEON PLC							17
	Average							22
	Weighted average by Cap.							24